official journal of the patent office - Controller General of Patents ...

(12)
(19)
(22)
PATENT APPLICATION PUBLICATION
INDIA
Date of filing of Application:24/08/2001
(21)
(43)
(54) Title of the Invention:. A PHARMACEUTICAL COMPOSITION
(51) International Classification : A61k[ 31/18
A61K 31/00
(31) Priority Document No.
60/106,664
:
(32) Priority Date : 02/11/1998
(33) Name of priority country USA
(86) International application No. : PCT/US99/25673
Filing Date : 02/11/1997
(87) International Publication No. : WO 00/25797
(61) Patent of Addition to
Application No.
: N.A.
(62) Divisional to Application No. : IN/PCT/2001/455/DEL
Filed On : 01/06/2001
Total No. of pages : 16
Application No.: IN/PCT/2001/00758/DEL
Publication Date:09/06/2006
(71) Name of Applicant : TRIANGLE
PHARMACEUTICALS , INC,
Address of the Applicant:
4 University Place, 4611 University Drive,
Durham, NC 27707, USA
(72) Name of the Inventor: :
FURMAN PHILLIP A.
PAINTER GEORGE R.
BARRY DAVID
ROUSSEAU FRANCK
Filed U/S 5(2) before The Patents
(Amendment) Ordinance, 2004 : YES
(57) Abstract: The present invention is directed to a method for treating hepatitis B virus infection in humans comprising
administering a synergistically effective amount of agents having known anti-hepatitis B virus activity in combination or
alternation. Specifically, the invention is directed to a method for treating hepatitis B virus infection comprising administering FTC
in combination or alternation with penciclovir, famciclovir or Bis-POM-PMEA. Additionally, the invention is directed to a method
for treating hepatitis B virus infection comprising administering L-FMAU in combination or alternation with DAPD, penciclovir or
Bis-POM-PMEA. The invention is further directed to a method for treating hepatitis B virus infection comprising administering
DAPD in combination or alternation with Bis-POM-PMEA.
The Patent Office Journal 09/06/2006 11119
A